Effects of Treatment With ENF (Electro Neuro Feedback) in the Reduction of Post-surgical Hematoma in Patients Undergoing Hip Replacement: Evaluation With Ultrasound Method

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-11-11

Study Completion Date

2023-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study evaluates patients with clinical evidence of post-surgical hematoma / seroma after hip replacement surgery. These patients will undergo ultrasound evaluation in the 4th (+/- 2) day post surgery, in which triaxial parameters of the hematoma will be measured. This evaluation will then be repeated after 5 treatment sessions with ENF (Electro Neuro Feedback). The patient will then be subjected to evaluation scales that allow to evaluate the subjective improvement of the state of well-being after treatment ENF (Electro Neuro Feedback) generates waveforms that change automatically when the impedance of the skin changes according to a compensation algorithm, i.e. according to Feedback (Feedback). T

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PENG Block Plus Lateral Femoral Cutaneous Nerve Block for Posterolateral-approached Total Hip Arthroplasty

NCT05432011

Pain Postoperative Pain Acute Pain +3 more

COMPLETED NA

Ultrasound Guided Nerve Block for Hip Fracture Pain Management at Emergency Department

NCT05403073

Hip Fractures Pain, Acute Ultrasound Therapy; Complications

UNKNOWN NA

Emergency Physician-performed Ultrasound-guided Femoral Nerve Blocks in Patients With Hip Fractures.

NCT05969561

Hip Fractures

RECRUITING NA

Ultra Sounded Guided Posterior Transverse Abdominis Plane & Lateral FEMORAL Cutaneous Nerve Blocks Analgesia Post Hip Hemiarthroplasty

NCT04475757

Postoperative Pain

COMPLETED

Deep Posterior Post Gluteal Compartment Block in Total Hip Arthroplasty: Feasability and Safety

NCT06896591

Total Hip Arthroplasty

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-surgical Hematoma, Hip Replacement , Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sessions with ENF (Electro Neuro Feedback).

The study evaluates patients with clinical evidence of post-surgical hematoma / seroma after hip replacement surgery. These patients will undergo ultrasound evaluation in the 4th (+/- 2) day post surgery, in which triaxial parameters of the hematoma will be measured. This evaluation will then be repeated after 5 treatment sessions with ENF (Electro Neuro Feedback).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gender: male and female
* Age: 35-85 years include
* Entry into the hospital rehabilitation program lasting at least 5 days following hip replacement surgery
* Absence in history of neurological or psychiatric disorders.
* Signature of the Informed Consent and consent to collaborate in all the procedures of the study

Exclusion Criteria

* Presence of severe neurological / psychiatric pathologies
* to sign the Informed Consense
* of serious cardiological pathologies that can compromise patient safety
* of Pace Maker or spinal cord stimulators or other subcutaneous electronic instruments
* of active tumors in the treatment area

Minimum Eligible Age

35 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No